Advertisement
top banner image  

topleft corner image     top right corner image
 
take action
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

jacc imaging image
bullet
bullet
bullet
bullet

acc links
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

JACC Homepage JACC Interventions Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?

     top nav image

     

J Am Coll Cardiol Img, 2009; 2:216-225, doi:10.1016/j.jcmg.2008.12.006
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Troughton, R. W.
Right arrow Articles by Richards, A. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Troughton, R. W.
Right arrow Articles by Richards, A. M.

State-of-the-Art-Paper

B-Type Natriuretic Peptides and Echocardiographic Measures of Cardiac Structure and Function

Richard W. Troughton, MB, ChB, PhD, FRACP*, A. Mark Richards, MD, PhD, DSc, FRACP

University Department of Medicine, University of Otago, Christchurch, Christchurch, New Zealand

* Reprint requests and correspondence: Dr. Richard W. Troughton, University Department of Medicine, University of Otago, Christchurch, PO Box 4345, Christchurch, New Zealand (Email: richard.troughton{at}cdhb.govt.nz).

Echocardiography and the B-type natriuretic peptides (BNPs) provide powerful incremental assessment of cardiac function, clinical status, and outcome across the spectrum of cardiac disease. There is strong evidence to support their integrated use in the diagnosis and management of cardiovascular disease. Amino-terminal pro-B-type natriuretic peptide (NT-proBNP) or BNP may guide more effective use of echocardiography in screening for asymptomatic left ventricular dysfunction; Doppler echocardiography improves the accuracy of heart failure diagnosis in the setting of intermediate BNP or NT-proBNP levels. Combined assessment of peptides and echocardiography provides more powerful stratification of risk across all stages of heart failure, and integrated use of both tests may identify subjects with valvular disease at greatest risk for progression and guide decision-making for timely intervention.

Key Words: natriuretic peptides • echocardiography • left ventricular function • Doppler echocardiography

Abbreviations and Acronyms
  aa = amino acid
  ADHF = acute decompensated heart failure
  BNP = B-type natriuretic peptide
  E/Ea = transmitral early filling velocity/early diastolic annular velocity
  LVEDP = left ventricular end diastolic pressure
  LVEF = left ventricular ejection fraction
  LVH = left ventricular hypertrophy
  NT-proBNP = amino-terminal pro-B-type natriuretic peptide
  PCWP = pulmonary capillary wedge pressure
  RV = right ventricle






Advertisement
 
   
 
home link current link search link archive link topics link cardiology careers link